4//SEC Filing
AKESIS PHARMACEUTICALS, INC. 4
Accession 0001209191-08-056584
CIK 0001042420operating
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 3:49 PM ET
Size
16.5 KB
Accession
0001209191-08-056584
Insider Transaction Report
Form 4
AKESIS PHARMACEUTICALS, INC.AKES.OB
Fine Stuart A
10% Owner
Transactions
- Purchase
Common Stock
2008-07-28$0.95/sh+110,050$104,548→ 133,800 total - Purchase
Common Stock
2008-08-01$0.80/sh+2,500$2,000→ 136,300 total - Purchase
Common Stock
2008-08-01$0.93/sh+42,101$39,154→ 197,401 total - Purchase
Common Stock
2008-09-23$0.49/sh+5,000$2,450→ 202,401 total - Purchase
Common Stock
2008-07-24$0.80/sh+2,500$2,000→ 12,500 total - Purchase
Common Stock
2008-07-24$0.94/sh+11,250$10,575→ 23,750 total - Purchase
Common Stock
2008-07-24$0.78/sh+10,000$7,800→ 10,000 total - Purchase
Common Stock
2008-08-01$0.85/sh+19,000$16,150→ 155,300 total
Footnotes (1)
- [F1]Between July 24 and September 23, 2008, the reporting person acquired 202,401 shares of Akesis Pharmaceuticals, Inc. through open market purchases under the Stuart A. Fine Defined Benefit Pension Plan uad 12/14/92.
Documents
Issuer
AKESIS PHARMACEUTICALS, INC.
CIK 0001042420
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001042420
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 3:49 PM ET
- Size
- 16.5 KB